You can see it everywhere: on TV and in newspapers and ads. The decades of struggle against cancer are paying off.
Fueled by innovation in new treatments, the underserved women’s health market has begun to turn the proverbial corner. What took it so long?
The osteoporosis drug market is bracing for the advent of potentially game-changing treatments.
Amgen’s osteoporosis drug Prolia is the category leader, projected to bring in $992 million in sales in 2016.
Only one new osteoporosis drug has been approved over the last six years.
Agencies are testing out strategies to reach gender parity at a time when questions of discrimination are still front and center.
Does virtual reality represent a new way for marketers to create immersive experiences — or is this just the industry’s latest shiny object?
The key to a successful ad? Think simple with an unexpected twist.
The power of hackathons is now magnified because of the power of the internet and social media, giving both patients and healthcare professionals a global platform for their voices.
FDA Commissioner Robert Califf has two plans for what he wants to achieve during his tenure. One is long-term. The other ends in early 2017.
Get the most out of
Register for free and enjoy unlimited access to: